Clinical trial
Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing…
NCT00367861 · Centre Leon Berard, Other · Completed
Key facts
| NCT number | NCT00367861 |
|---|---|
| Title | Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance |
| Official title | A Prospective Multicentric Randomized Study of Glivec® in Patients With Advanced Gastrointestinal Stromal Tumors Expressing C-kit Comparing Treatment Interruption After 5 Years vs Treatment Maintenance |
| Lead sponsor | Centre Leon Berard, Other |
| Collaborators | Gustave Roussy, Cancer Campus, Grand Paris |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sarcoma, Gastro-intestinal Stromal Tumors (GIST) |
| Intervention type | Drug |
| Interventions | interruption of Glivec® |
| Enrollment | 564 |
| Start date | May 1, 2002 |
| Primary completion | Apr 1, 2012 |
| Completion | May 1, 2013 |
| First posted | Aug 23, 2006 |
| Last update posted | Feb 24, 2014 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: